Further studies confirm that CHD1 plays a key role in myeloid-derived suppressor cell recruitment and find that CHD1/IL6 is a major regulator of the immunosuppressive tumor microenvironment in prostate cancer (Zhao et al., 2020). The gene discussed is CHD1; the disease is neoplasm.